Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-27

Clinical Trial Update: Urea Cream Prevention for Capecitabine Associated Hand Foot Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial update evaluating urea cream for prevention of capecitabine-associated hand-foot syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • Urea cream (urea cream)

Snippet

Sponsor: Mahidol University | Conditions: Hand-Foot Syndrome | Phase 2, Phase 3 | Status: UNKNOWN